Don't miss our LEUKEMIA 360 partnership event, registration is limited! Access the website

News

Un partenariat inédit, lancé durant Septembre Rouge !

Sept. 30, 2024, 6:23 p.m.

Les instituts Carnot OPALE et CALYM et le Paris-Saclay Cancer Cluster s’associent pour accélérer la recherche en oncohématologie et soutenir l'innovation thérapeutique.

> Read more

Lancement de l’appel à candidatures pour le programme OncoEntrepreneur 2024

Sept. 26, 2024, 12:15 p.m.

L’Institut Carnot OPALE et le PSCC ouvrent les candidatures pour le programme OncoEntrepreneur, dédié aux projets Healthtech en oncologie. Formation, accompagnement et networking au programme !

> Read more

We are participating at OncoSTART alongside two spin-offs !

Sept. 24, 2024, 10:12 a.m.

First day of the OncoSTART Entrepreneurship School at Paris Saclay Cancer Cluster (PSCC) premises !

> Read more

Public-Private Partnerships in the field of Leukemia and Related Diseases

July 25, 2024, 12:27 p.m.

Driving innovation through public-private partnerships

> Read more

Transforming leukemia treatment: Inside CAR-T cell therapy

July 23, 2024, 8:17 p.m.

CAR-T cell therapy represents a significant leap forward in leukemia treatment.

> Read more

LEUKEMIA 360 : Meet the leukemia experts in Paris

July 23, 2024, 4:57 p.m.

Organized by Opale, we expect the 2024 edition of LEUKEMIA 360 to foster value-added R&D partnerships between industry and academia and accelerate innovation in the field of leukemia and related diseases.

> Read more

Breaking new ground in Leukemia R&D !

July 9, 2024, 6:58 p.m.

We are proud to announce a strategic partnership with the renowned Shanghai Institute of Hematology (SIH) at Ruijin Hospital, China.

> Read more

Du nouveau dans l’équipe

June 6, 2024, 5:12 p.m.

L'équipe OPALE s'agrandit en 2024

> Read more

UNITC labellisé par l'INCA

April 16, 2024, 1:21 p.m.

Le consortium dédié aux CAR-T cells UNITC a été labellisé par l'INCa

> Read more